… that oral small molecule antivirals that halt SARS-CoV-2 … administration is required, oral
antivirals offer treatments in an … The advent of additional oral antivirals, the assessment of …

… of oral drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by …
of the first-generation oral antiviral agents against SARS-CoV-2. Parenteral therapeutics, …

The first two oral antivirals, molnupiravir and nirmatrelvir–ritonavir, are now becoming available
in many countries. These medicines will be indicated to treat mild-to-moderate COVID-…

… rates, outbreaks of new SARS-CoV-2 variants, incomplete … oral antiviral drugs that can
treat SARS-CoV-2 infection at an early stage. On 4 th November 2021, the first oral antiviral for …

… orally bioavailable SARS-CoV-2 main protease inhibitor with in vitro pan-human coronavirus
antiviral … the in vitro cellular antiviral activity of PF-07321332 against SARS-CoV-1, MERS-…

… SARS-CoV-2 in part I, and antiviral mechanisms plus trial evidence for viruses other than
SARS-CoV-2 … CQ and HCQ are reported to have strong antiviral property for SARS-CoV in vitro. …

… activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
human … coronavirus (SARS-CoV) or Middle East respiratory syndrome coronavirus (MERS-CoV) …

… RSV and SARS-CoV-2 revealed transcriptional stalling after incorporation. Once-daily oral
… or 20 mg/kg in ferrets infected with different SARS-CoV-2 variants of concern, initiated 24 or …

… antiviral therapies are widely available, they are underutilized, possibly because of reports
of SARS-CoV… To enhance current understanding of rebound, CDC reviewed SARS-CoV-2 …

… , severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly … oral antiviral
agents are urgently needed to treat coronavirus disease-2019 (COVID-19), block SARS-CoV-…